Wu et al. found decreased expression of SIRT1, SIRT3, SIRT5, and SIRT6 in NAFLD patients, alongside increased lipogenic gene expression and SIRT4 [155]. Here, SIRT3 is linked to metabolic dysfunction-associated steatotic liver disease.